Raise Money for Salivary Gland Cancer Treatment

PavelAndreev.ORG is an international crowdfunding platform for raising donations, through which thousands of charitable online campaigns have been organized. The platform is free for anyone who wants to start a campaign.

Start a campaign

How to start a salivary gland cancer treatment fundraiser?

Your fundraiser on PavelAndreev.ORG starts in three quick and easy steps:

Create a campaign

Start your salivary gland cancer treatment fundraising campaign in minutes by following the platform's steps and instructions.

Admin review & support

A platform administrator will review your campaign and help you prepare it in the best possible way.

Share & launch

Share your salivary gland cancer treatment fundraising campaign on social media and receive donations from people who care.

Create a campaign

Start your salivary gland cancer treatment fundraising campaign in minutes by following the platform's steps and instructions.

Admin review & support

A platform administrator will review your campaign and help you prepare it in the best possible way.

Share & launch

Share your salivary gland cancer treatment fundraising campaign on social media and receive donations from people who care.

Start a campaign

Types of medical costs in salivary gland cancer treatment

  • Diagnostic and Pathology Costs: Expenditures for initial clinical evaluation, fine-needle aspiration cytology, ultrasound-guided core needle biopsy, histopathological examination, immunohistochemistry (IHC), and molecular or genomic testing.
  • Diagnostic Imaging Costs: Direct costs for baseline and diagnostic imaging modalities, including diagnostic CT, magnetic resonance imaging (MRI), ultrasound, and PET/CT fusion imaging.
  • Therapeutic and Clinical Delivery Costs: Costs associated with surgical procedures, radiation therapy fractions, systemic drug administration, and clinical facility attendances.
  • Patient Cost-Sharing Types: Out-of-pocket expenses borne by the patient, including insurance deductibles, co-insurance percentages, co-payments, pharmacy benefit versus medical benefit cost-sharing arrangements, and financial counseling fees.

  • Screening and Diagnostic Evaluation Costs: Expenses for evaluating suspected clinical signs, symptoms, or masses prior to formal histological confirmation.
  • Initial Work-Up and Staging Costs: Baseline diagnostic imaging, biopsy verification, and comprehensive clinical TNM staging prior to initiating primary therapy.
  • Neoadjuvant Therapy Costs: Systemic or targeted treatments administered before primary surgery or radiation to reduce tumor volume.
  • Primary Definitive Treatment Costs: Main intended-curative interventions, including primary surgical resection and definitive radiation therapy.
  • Adjuvant Therapy Costs: Postoperative radiation therapy, concurrent chemoradiotherapy, or hormonal therapy administered to eradicate residual micro-disease and decrease recurrence risks.
  • Interim Restaging and Response Monitoring Costs: Diagnostic evaluations and imaging scans performed during active treatment cycles to monitor therapeutic response.
  • Restaging and Salvage Treatment Costs: Diagnostic re-evaluation, restaging imaging, and secondary curative or salvage interventions following suspected recurrence or disease progression.
  • Post-Treatment Surveillance Costs: Long-term follow-up expenses, including periodic clinical examinations and routine surveillance imaging in asymptomatic individuals.

  • Travel and Logistical Expenses: Long-distance travel, transportation, and temporary lodging costs incurred by patients traveling to specialized academic or tertiary cancer centers.
  • Geographic Availability Disparity Costs: Cost variations arising from regional disparities in facility infrastructure and specialized technology access (e.g., proton or carbon-ion centers vs. standard radiation facilities).
  • Demographic and Residential Disparity Costs: Cost and outcome variations associated with rural versus urban residency, local healthcare infrastructure capacity, and patient socioeconomic status.
  • Reimbursement and Payer Jurisdiction Costs: Variance between nationalized public health systems and private health insurance models, out-of-network referral fees, administrative prior authorization burdens, and insurance coverage denials.
  • Indirect Societal and Financial Toxicity Costs: Indirect financial toxicity, loss of employment or caregiver productivity, and broader societal economic expenditures.

  • Major Salivary Gland Treatment Costs: Surgical resections (e.g., partial/total parotidectomy, submandibular gland excision) and targeted radiation fields directed at primary tumors in the major glands.
  • Minor Salivary Gland and Mucosal Site Costs: Surgical excision and site-specific reconstructive care for tumors located across minor mucosal sites, such as the oral cavity, hard palate, nasal cavity, or paranasal sinuses.
  • Nodal and Neck Dissection Costs: Lymph node staging, elective or therapeutic neck dissection, and elective neck irradiation based on regional nodal involvement.
  • Complex Structure and Deep Invasion Costs: Specialized surgical techniques and complex radiation planning required for invasive disease involving critical anatomical structures, such as the facial nerve, carotid artery, skull base, or spine.
  • Anatomical Reconstruction Costs: Cosmetic and functional reconstruction, nerve grafting, or static slings tailored to specific defect locations.

  • Surgical Innovation Costs: Traditional open surgical procedures compared to advanced minimally invasive, endoscopic, or robot-assisted surgical techniques.
  • Advanced Radiation Technology Costs: Standard photon radiotherapy (3D-CRT, IMRT) versus specialized particle modalities (Proton Beam Therapy [PBT], Carbon-Ion Radiotherapy [CIRT], or fast neutron radiation).
  • Molecular Profiling and Biomarker Testing Costs: High-throughput next-generation sequencing, whole-genome/exome sequencing, and biomarker testing for actionable target drivers (e.g., HER2, AR, NOTCH, HRAS, NTRK).
  • Targeted and Biologic Systemic Drug Costs: Acquisition expenses for precision pharmacotherapies, including tyrosine kinase inhibitors (e.g., lenvatinib), antibody-drug conjugates (e.g., trastuzumab deruxtecan), and combined androgen blockade.
  • Clinical Trial and Regulatory Pathway Costs: Protocol-driven clinical trial evaluations, expanded access or compassionate use programs, and orphan drug access pathways.

  • Facial Reanimation and Neuromuscular Retraining Costs: Specialized facial physical therapy, dynamic nerve-muscle flap transfers, static slings, gold eyelid weighting implants, and botulinum toxin injections for synkinesis.
  • Oral, Dental, and Prosthodontic Rehabilitation Costs: Pre- and post-radiation dental care, prosthodontic restoration, and jaw trismus rehabilitation using custom mouth-opening devices.
  • Speech, Swallowing, and Respiratory Therapy Costs: Swallowing evaluations and therapy, pharyngeal strengthening exercises, expiratory strength training, and tracheostomy decannulation care.
  • Chronic Toxicity and Supportive Care Costs: Long-term management of xerostomia, radiation-induced tissue fibrosis, lymphedema decompression, chronic pain, and fatigue.
  • Multiple Chronic Conditions (MCC) Management Costs: Care coordination and treatment plan modifications required to manage co-existing chronic health conditions.

  • Facility Capital and Infrastructure Expenditures: Initial capital investments for specialized radiation centers, particle accelerators, shielding construction, and multi-room treatment suites.
  • Annual Operational and Maintenance Expenditures: Equipment servicing, treatment planning systems, quality assurance infrastructure, and facility overhead.
  • Multidisciplinary Team Personnel Costs: Staffing expenditures for integrated care teams including head and neck surgeons, radiation oncologists, medical oncologists, pathologists, radiologists, speech pathologists, and nutritionists.
  • Administrative and Payer Interaction Costs: Institutional overhead associated with navigating prior authorizations, handling insurance appeals, billing management, and providing financial counseling services.
  • Inpatient versus Outpatient Operational Costs: Operating costs across inpatient surgical admissions, ambulatory surgery units, and outpatient care centers.

  • Palliative Radiation Therapy Costs: Short-course hypofractionated or palliative radiation regimens (e.g., the QUAD SHOT regimen) utilized for local symptom control.
  • Palliative Systemic Therapy Costs: Non-curative chemotherapy or targeted systemic regimens aimed at disease control in advanced or metastatic settings.
  • Symptom Management and Pharmacotherapy Costs: Medications and supportive therapies for controlling cancer pain, antiemesis, and treatment toxicities.
  • Psychosocial and Supportive Care Costs: Social work services, case management, psychological support, and structured distress management.
  • End-of-Life Care Coordination Costs: Hospice services, home healthcare coordination, and non-curative comfort care planning.

PavelAndreev.ORG results:

Donor trust and the security of funds on the platform are our highest priority. Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Total you have donated

49.57M EUR

Regardless of its size, every donation helps save a human life or successfully carry out a social cause.

Total number of donations

1 497 541

The contribution of a large number of people reflects the commitment of our society and contributes to the success of the campaigns.

Number of active campaigns

665

Every campaign is a unique cause and offers an opportunity to bring about positive change in our society.

Be proactive. Start successful campaigns and raise donations! With PavelAndreev.ORG you can count on modern methods for receiving donations, a team that will be by your side throughout your campaign, security for your money, and 24/7 access to it.

Start a campaign

Three important reasons to start a campaign on PavelAndreev.ORG

At PavelAndreev.ORG we use new technologies to let you support fundraising campaigns quickly and easily.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Trust and security

To guarantee the security of funds, we use the most modern and proven service providers.

Easy & convenient donations

The platform supports multiple payment methods, through which people from all over the world can donate to your campaign.

Global audience

PavelAndreev.ORG is an international crowdfunding platform with a global audience of donors who want to support meaningful causes.

Cancer statistics in the United States

Start a campaign
Start a campaign

PavelAndreev.ORG is a crowdfunding platform for organizing fundraising donation campaigns to raise money, managed by Foundation Pavel Andreev (UIC: 206678629) with founder and CEO Pavel Andreev. All donations made through the fundraising platform PavelAndreev.ORG are administered by the team of Pavel Andreev and the Foundation Pavel Andreev.

Google News: PavelAndreev.ORG, Pavel Andreev.